UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000043809
Receipt No. R000049980
Scientific Title A Randomized Controlled Trial of the Efficacy of Opioid-Free Anesthesia in Pediatric Cardiac Surgery
Date of disclosure of the study information 2021/04/03
Last modified on 2021/04/01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Study on the Efficacy of Opioid-Free Anesthesia in Pediatric Cardiac Surgery
Acronym A Study on the Efficacy of Opioid-Free Anesthesia in Pediatric Cardiac Surgery
Scientific Title A Randomized Controlled Trial of the Efficacy of Opioid-Free Anesthesia in Pediatric Cardiac Surgery
Scientific Title:Acronym A Randomized Controlled Trial of the Efficacy of Opioid-Free Anesthesia in Pediatric Cardiac Surgery
Region
Japan

Condition
Condition Atrial septal defect and ventricular septal defect
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To determine whether opioid-free anesthesia with pain control by intercostal nerve block accelerates weaning from ventilation compared with anesthesia with pain control by opioids in pediatric cardiac surgery.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase

Assessment
Primary outcomes Success rate of extubation in the operating room
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Fentanyl 3mcg/kg is administered at the time of anesthesia induction, and ultrasound-guided intercostal nerve blocks (3-5 mL of 0.2-0.375% ropivacaine per intercostal space) are performed in the planned open intercostal space and one intercostal space above and below it for a total of three intercostal spaces before the procedure.
Interventions/Control_2 Fentanyl 3 mcg/kg is administered at the time of anesthesia induction, and fentanyl 10 mcg/kg is at the start of surgery.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
12 years-old >
Gender Male and Female
Key inclusion criteria 1) Patients undergoing radical minimally invasive cardiac surgery with lateral chest opening for atrial septal defect or ventricular septal defect
2) Patients under 12 years of age at the time of obtaining consent
3) Patients with written consent from a surrogate
Key exclusion criteria 1) Patients taking antithrombotic or anticoagulant medication
2) Patients with suspected coagulation disorders based on preoperative blood coagulation tests
3) Patients undergoing emergency surgery
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Tomoyuki
Middle name
Last name Kanazawa
Organization Okayama University Hospital
Division name Department of Anesthesiology and Resuscitology
Zip code 700-8558
Address 2-5-1, Shikata-cho, Kita-ku, Okayama, Japan
TEL 086-235-7778
Email tyskanazawa@gmail.com

Public contact
Name of contact person
1st name Tatsuhiko
Middle name
Last name Shimizu
Organization Okayama University Hospital
Division name Department of Anesthesiology and Resuscitology
Zip code 700-8558
Address 2-5-1, Shikata-cho, Kita-ku, Okayama, Japan
TEL 086-235-7778
Homepage URL
Email t.shimizu.8479@gmail.com

Sponsor
Institute Okayama University Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee
Address 2-5-1, Shikata-cho, Kita-ku, Okayama, Japan
Tel 086-235-6938
Email mae6605@adm.okayama-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 04 Month 03 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 03 Month 20 Day
Date of IRB
Anticipated trial start date
2021 Year 06 Month 22 Day
Last follow-up date
2027 Year 10 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 04 Month 01 Day
Last modified on
2021 Year 04 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049980

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.